ŠMÍD, Martin, Tamara BARUSOVÁ, Jiří JARKOVSKÝ, Ondřej MÁJEK, Tomáš PAVLÍK, Lenka PŘIBYLOVÁ, Josefína WEINEROVÁ, Milan ZAJÍČEK a Jan TRNKA. Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023. Eurosurveillance. European Centre for Disease Prevention and Control, 2024, roč. 29, č. 35, s. 1-10. ISSN 1025-496X. Dostupné z: https://dx.doi.org/10.2807/1560-7917.ES.2024.29.35.2300690.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023
Autoři ŠMÍD, Martin, Tamara BARUSOVÁ, Jiří JARKOVSKÝ (203 Česká republika, domácí), Ondřej MÁJEK (203 Česká republika, domácí), Tomáš PAVLÍK (203 Česká republika, domácí), Lenka PŘIBYLOVÁ (203 Česká republika, domácí), Josefína WEINEROVÁ, Milan ZAJÍČEK a Jan TRNKA (garant).
Vydání Eurosurveillance, European Centre for Disease Prevention and Control, 2024, 1025-496X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30303 Infectious Diseases
Stát vydavatele Švédsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 19.000 v roce 2022
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2807/1560-7917.ES.2024.29.35.2300690
UT WoS 001308042700002
Klíčová slova anglicky COVID-19; SARS-CoV-2 Omicron subvariants; post-vaccination; post-infection; hybrid immunity
Štítky 14119612, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 1. 10. 2024 10:04.
Anotace
Background COVID-19 remains a major infectious disease with substantial implications for individual and public health including the risk of a post-infection syndrome, long COVID. The continuous changes in dominant variants of SARS-CoV-2 necessitate a careful study of the effect of preventative strategies. Aim We aimed to estimate the effectiveness of post-vaccination, post-infection and hybrid immunity against severe cases requiring oxygen support caused by infections with SARS-CoV-2 variants BA1/2 and BA4/5+, and against long COVID in the infected population and their changes over time. Methods We used a Cox regression analysis with time-varying covariates and calendar time and logistic regression applied to national-level data from Czechia from December 2021 until August 2023. Results Recently boosted vaccination, post-infection and hybrid immunity provide significant protection against a severe course of COVID-19, while unboosted vaccination more than 10 months ago has a negligible protective effect. The post-vaccination immunity against the BA1/2 or BA4/5+ variants, especially based on the original vaccine types, appears to wane rapidly compared with post-infection and hybrid immunity. Once infected, however, previous immunity plays only a small protective role against long COVID. Conclusion Vaccination remains an effective preventative measure against a severe course of COVID-19 but its effectiveness wanes over time thus highlighting the importance of booster doses. Once infected, vaccines may have a small protective effect against the development of long COVID.
Návaznosti
MUNI/A/1132/2022, interní kód MUNázev: Matematické a statistické modelování 7
Investor: Masarykova univerzita, Matematické a statistické modelování 7
101063853, interní kód MUNázev: Models with cross-interactions between partial dynamical processes aiming to understand significant or abrupt dynamic changes. (Akronym: CrossInteractions)
Investor: Evropská unie, Models with cross-interactions between partial dynamical processes aiming to understand significant or abrupt dynamic changes., Marie Skłodowska-Curie Postdoctoral Fellowships (MSCA PF)
VytisknoutZobrazeno: 4. 10. 2024 00:20